APLT Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Applied Therapeutics Inc - Alpha Spread

Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 8.2683 USD 5.33% Market Closed
Market Cap: 1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

Wall Street
Price Targets

APLT Price Targets Summary
Applied Therapeutics Inc

Wall Street analysts forecast APLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLT is 11.628 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.

Lowest
Price Target
7.07 USD
14% Downside
Average
Price Target
11.628 USD
41% Upside
Highest
Price Target
14.7 USD
78% Upside
Applied Therapeutics Inc Competitors:
Price Targets
688366
Shanghai Haohai Biological Technology Co Ltd
70% Upside
4974
Takara Bio Inc
58% Upside
ELDN
Eledon Pharmaceuticals Inc
467% Upside
ALGEN
Genoway SA
77% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
18% Upside
603087
Gan & Lee Pharmaceuticals
75% Upside
MGNX
MacroGenics Inc
117% Upside
2INV
2Invest AG
76% Downside

Revenue
Forecast

Revenue Estimate
Applied Therapeutics Inc

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 141%.

N/A
Past Growth
141%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Applied Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APLT's stock price target?
Price Target
11.628 USD

According to Wall Street analysts, the average 1-year price target for APLT is 11.628 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.

What is Applied Therapeutics Inc's Revenue forecast?
Projected CAGR
141%

The compound annual growth rate of Applied Therapeutics Inc's revenue for the next 3 years is 141%.

Back to Top